Technology | June 16, 2015

Philips Launches Anatomically Intelligent Quantification Tool for Cardiac Ultrasound Imaging

HeartModel(A.I.) provides reproducible ultrasound results, fast exam times and seamless workflow

Philips, Epiq 7, Anatomically Intelligent Ultrasound, AIUS, cardiac ultrasound
Philips, Epiq 7, Anatomically Intelligent Ultrasound, AIUS, cardiac ultrasound

June 16, 2015 - Royal Philips announced the introduction of HeartModelA.I., a new Anatomically Intelligent Ultrasound (AIUS) tool that brings advanced quantification, automated 3-D views and robust reproducibility to cardiac ultrasound imaging. Philips' fastest 3-D AIUS ultrasound measurement method was unveiled on its Epiq 7 ultrasound system during the American Society of Echocardiography (ASE) annual meeting in Boston.

Using HeartModelA.I., clinicians can quickly, easily and confidently assess disease states, determine treatment and guide related therapies. In a recent comparison, exams with HeartModelA.I. were shown to be three to six times faster than conventional 2-D exams in gathering left ventricular and atrial dimensions and volumes (LV and LA), while offering the many benefits of 3-D imaging. With a rich digital database of anatomical structural models and adaptive system technology, HeartModelA.I. has access to advanced clinical information that automatically adapts to variability in patient anatomy. This knowledge-base identification and patient-specific adaptation provides proven quantification of the left ventricle and atrium, and display of routine apical views.

HeartModelA.I. is part of a suite of new tools and technologies available on Philips' Epiq 7 ultrasound system. The Epiq 7 system is designed to enhance automation and reproducibility to help address some of the most critical strains on overburdened hospitals and healthcare systems challenged to provide higher quality care at a lower cost. Epiq 7 is known for its high-image quality, advanced automation and reproducibility, and ergonomic design.

"Traditionally, collecting and analyzing heart measurements have been time-consuming, difficult processes with resulting variability that can impact diagnostic confidence," said Roberto Lang, M.D., professor of medicine and director of noninvasive cardiac imaging laboratories, University of Chicago Medicine. "Today's busy, constrained clinical environments need simplified methods to help provide high-quality care at low costs. Philips' HeartModelA.I. helps take the variability out of critical cardiac ultrasound measurements and enables time savings, broader applicability and accurate data to inform better delivery of care."  

HeartModelA.I. will be made available on the Epiq 7 ultrasound system in the United States beginning in August and globally by the end of the year.

For more information: www.philips.com

Related Content

ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
Medical Imaging Rates Continue to Rise Despite Push to Reduce Their Use
News | Radiology Imaging | September 03, 2019
Despite a broad campaign among physician groups to reduce the amount of medical imaging, use rates of various scans...
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
CIRS Launches Ultrasound Quality Assurance Software
Technology | Quality Assurance (QA) | August 30, 2019
August 30, 2019 — The CIRS Ultrasound...
Terason Partners With DiA Imaging Analysis for Point-of-care Cardiac Ultrasound AI
News | Cardiovascular Ultrasound | August 26, 2019
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-...
Exo Imaging Raises $35 Million for Developmental Ultrasound Platform
News | Ultrasound Imaging | August 23, 2019
Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on...
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...